Scalper1 News
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry’s drug-pricing practices and fears of greater regulation. But two biotechs with top fundamentals — Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN), the focus of the Screen of the Day — have maintained strong ratings and held up in Scalper1 News
Scalper1 News